Cargando…

Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers

Detalles Bibliográficos
Autores principales:	Tré-Hardy, Marie, Cupaiolo, Roberto, Wilmet, Alain, Beukinga, Ingrid, Blairon, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214908/ https://www.ncbi.nlm.nih.gov/pubmed/34161817 http://dx.doi.org/10.1016/j.jinf.2021.06.017

Ejemplares similares

Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary
por: Tré-Hardy, Marie, et al.
Publicado: (2021)

Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers
por: Tré-Hardy, Marie, et al.
Publicado: (2021)

Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital
por: Blairon, Laurent, et al.
Publicado: (2020)

The challenge of screening SARS-CoV-2 variants of concern with RT-qPCR: One variant can hide another
por: Blairon, Laurent, et al.
Publicado: (2021)

Assessment 2 months after the administration of a 3rd dose mRNA: a new variant-adapted vaccine is expected
por: Tré-Hardy, Marie, et al.
Publicado: (2022)

Enterococcus thailandicus, an unusual pathogen in humans encountered in an intra-abdominal infection
por: Mbouche, Patricia, et al.
Publicado: (2023)

Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak
por: Blairon, Laurent, et al.
Publicado: (2021)

The role of serology for COVID-19 control: Population, kinetics and test performance do matter
por: Tré-Hardy, Marie, et al.
Publicado: (2020)

Clinical evaluation of the GSD NovaPrime® SARS-CoV-2 RTq-PCR assay
por: Tré-Hardy, Marie, et al.
Publicado: (2022)

Waning of Antibody Response Among Vaccinees who Received Two Doses of Covishield Vaccine
por: Haritay, Shivani, et al.
Publicado: (2023)

Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar
por: Abu-Raddad, Laith J., et al.
Publicado: (2022)

Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong
por: Peng, Qiaoli, et al.
Publicado: (2022)

Immunogenicity of Sars-Cov-2 mRNA 1273 Vaccine in Patients with Lymphoid Malignancies
por: Dong, Ning, et al.
Publicado: (2021)

Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study
por: Florea, Ana, et al.
Publicado: (2022)

Immunogenicity and safety of heterologous mRNA-1273/MVC-COV1901 vaccination versus homologous mRNA1273 vaccination: A randomized, double-blind controlled study
por: Huang, Szu-Ting, et al.
Publicado: (2023)

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
por: Anderson, Evan J., et al.
Publicado: (2020)

Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
por: van Leeuwen, Leanne P.M., et al.
Publicado: (2022)

Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial
por: El Sahly, Hana M, et al.
Publicado: (2022)

Safety and immunogenicity of a third dose of mRNA‐1273 vaccine among cancer patients
por: Giuliano, Anna, et al.
Publicado: (2023)

Reduced neutralizing antibody response in naïve Covishield vaccinees against Omicron emphasizes booster vaccination
por: Yadav, Pragya D., et al.
Publicado: (2022)

Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies
por: Jiménez, Moraima, et al.
Publicado: (2022)

Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study
por: Bruxvoort, Katia J., et al.
Publicado: (2021)

Waning of 2-Dose BNT162b2 and mRNA-1273 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Accounting for Depletion-of-Susceptibles Bias
por: Andrejko, Kristin L, et al.
Publicado: (2023)

The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees
por: Van Coillie, Julie, et al.
Publicado: (2022)

mRNA-1273: Myocarditis: case report
Publicado: (2021)

mrna-1273: Erythema nodosum: case report
Publicado: (2021)

mrna-1273: Immediate hypersensitivity: case report
Publicado: (2021)

mrna-1273: Acute myocarditis: case report
Publicado: (2021)

mRNA-1273: Myopericarditis: case report
Publicado: (2021)

mRNA 1273: Anaphylaxis: case report
Publicado: (2021)

mrna-1273: Haematuria: 2 case reports
Publicado: (2021)

Adventitious viral genomes in vaccines but not in vaccinees.
por: Weiss, R A
Publicado: (2001)

Contextualizing Naive Bayes Predictions
por: Loor, Marcelo, et al.
Publicado: (2020)

A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: An interim report
por: Masuda, Taisei, et al.
Publicado: (2022)

Immunogenicity and safety of homologous and heterologous ChAdOx1-S and mRNA-1273 vaccinations in healthy adults in Taiwan
por: Kang, Chun-Min, et al.
Publicado: (2022)

The Waning of the Plague
Publicado: (1897)

Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients
por: Haller, Maria C., et al.
Publicado: (2022)

Full and Booster Doses of SARS-CoV-2 mRNA-1273 Vaccine Increase Waning Antibody Levels After Completed Vaccination Among Dialysis Patients at a Large Dialysis Organization
por: Ficociello, Linda H, et al.
Publicado: (2022)

112P Immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in cancer patients receiving immunotherapy agents
por: Muñoz, F. Longo, et al.
Publicado: (2021)

Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours
por: Oosting, Sjoukje F, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1o20mtanhh41qnpqtqng5ar6ml